Cyrus Harmon, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 25,000 shares at $13.30 ($335K) on 2023-12-29, disclosed to the SEC on 2024-01-02.
Open-market sale of $334k OLMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.30 | 22,500 | $299K | 89.5% |
| 2 | $14.10 | 2,500 | $35K | 10.5% |
| Total | $13.38 avg | 25,000 | $335K | 100% |
| Filing → |
| OLMA | SELL | 2026-01-16 | $102K | — | Filing → |
| OLMA | SELL | 2025-12-29 | $164K | — | Filing → |
| OLMA | SELL | 2025-09-18 | $285K | — | Filing → |